Providing a support network for patients suffering from inflammatory bowel disease proves helpful for patient recovery, according to a Pain Medicine News report.
GI & Endoscopy
The Nashville-based pharmaceutical company Cumberland Pharmaceuticals has received FDA clearance for a randomized, placebo-controlled Phase II clinical study. The study will investigate Portaban, a treatment Cumberland Pharmaceuticals developed for liver cyrossis patients.
University Gastroenterology and its 19 offices were victims of a data hacking scam, where an individual gained access to the network, copied information for 14,000 patients and then encrypted it, NBC reports.
The Kentucky-based University of Louisville has received a five-year $11.5 million grant from the NIH's Centers of Biomedical Research Excellence, according to the Louisville Courier-Journal.
Nicole Bradberry will be the next CEO of Captify Health. Here's what you need to know.
Advertisement
Here are six updates on key gastroenterology and endoscopy companies.
Researchers at the University of Pennsylvania's school of medicine in Philadelphia may have found a new way to provide patients with organ transplants.
Endoscopic suturing devices are more effective than endoscopic clips when closing colonic perforations, according to a recent study published in the journal Gastrointestinal Endoscopy.
The New York City-based Mount Sinai Hospital now uses Cellvizio, an endomicroscopy diagnostic device.
Mount Sinai Hospital and the New York Society of Gastroenterology partnered to host an educational program on Confocal Laser Endomicroscopy.